Insight Molecular Diagnostics (IMDX)'s 30-day implied volatility (IV30) was 114.1% at the close on November 6, 2026, up from 112.7% the day before, against a 52-week range of 66.3% to 153.0%. Its 20-day historical volatility was 109.1%.
Data as of November 6, 2026.